HLA-G in asthma and its potential as an effective therapeutic agent

Allergol Immunopathol (Madr). 2023 Jan 1;51(1):22-29. doi: 10.15586/aei.v51i1.650. eCollection 2023.

Abstract

Objective: Asthma is a heterogeneous disease. Severity of asthma and sensitivity to medications vary across asthma subtypes. Human leukocyte antigen (HLA)-G has a wide range of functions in normal and pathological physiology. Due to its powerful immune function, HLA-G participates in the pathogenesis of different asthma phenotypes by regulating the activity and function of various immune cells. The mechanism of HLA-G in asthma is not fully clear, and there is no consensus on its mechanism in asthma. Further studies are needed to explore the role of HLA-G in different phenotypes of human asthma.

Methods: Observational study.

Results: HLA-G is an important immunomodulatory factor in asthma. Studies have found different levels of HLA-G in patients with different asthma subtypes and healthy controls, but other studies have come to the opposite conclusion.

Conclusion: We speculate that further study on the mechanism of HLA-G in asthma pheno-types may explain some of the contradictions in current studies. Findings should provide information regarding the potential of HLA-G as a novel target for asthma diagnosis and treatment.

Keywords: Asthma; Asthma Subtypes; HLA-G; Inflammation.

Publication types

  • Review

MeSH terms

  • Asthma*
  • HLA-G Antigens* / genetics
  • Humans
  • Observational Studies as Topic
  • Phenotype

Substances

  • HLA-G Antigens